Perioperative management including new pharmacological vistas for patients with pulmonary hypertension for noncardiac surgery

Current Opinion in Anaesthesiology

Volumn 21, Issue 4, 2008, Pages 467-472

  Fox, Charles ^a   Kalarickal, Philip L ^a   Yarborough, Michael J ^a   Jin, John Y ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anesthetic management; Pharmacologic agents; Right ventricular function

Indexed keywords

ADRENALIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRONCHODILATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPYRIDAMOLE; DOBUTAMINE; DOPAMINE; ETOMIDATE; GLYCERYL TRINITRATE; INHALATION ANESTHETIC AGENT; INOTROPIC AGENT; KETAMINE; LOCAL ANESTHETIC AGENT; MILRINONE; NARCOTIC AGENT; NITROPRUSSIDE SODIUM; NITROUS OXIDE; NORADRENALIN; OPIATE; PHENYLEPHRINE; PROPOFOL; PROSTACYCLIN; SILDENAFIL; THIOPENTAL; VASODILATOR AGENT; VASOPRESSIN;

ANESTHESIA; ANESTHESIA INDUCTION; BALANCED ANESTHESIA; CARDIAC PATIENT; CLINICAL FEATURE; DISEASE CLASSIFICATION; DRUG MECHANISM; DRUG MEGADOSE; ECHOCARDIOGRAPHY; EPIDURAL ANESTHESIA; FUNCTIONAL ASSESSMENT; GENERAL ANESTHESIA; HEART ARRHYTHMIA; HEART ASSIST DEVICE; HEART MUSCLE CONTRACTILITY; HEMODYNAMIC MONITORING; HUMAN; HYPOTENSION; LABORATORY TEST; LUNG ARTERY PRESSURE; LUNG MODEL; LUNG VASCULAR RESISTANCE; MORBIDITY; NONHUMAN; OXYGEN THERAPY; PATHOPHYSIOLOGY; PATIENT MONITORING; PERIOPERATIVE PERIOD; PEROPERATIVE CARE; POSTOPERATIVE CARE; PREMEDICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REGIONAL ANESTHESIA; REPEATED DRUG DOSE; REVIEW; SIDE EFFECT; SURGICAL MORTALITY; SYSTEMIC VASCULAR RESISTANCE; TREATMENT OUTCOME;

HUMANS; HYPERTENSION, PULMONARY; PERIOPERATIVE CARE; SURGICAL PROCEDURES, OPERATIVE;

EID: 66449136428     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/ACO.0b013e3283007eb4     Document Type: Review

References (39)

1. Gaine S. Pulmonary hypertension. JAMA 2000; 284:3160-3168.
2. Loyd JE, Butler MG, Foroud TM, et al. Genetic anticipation and abnormal gender ratio at birth in familial primary pulmonary hypertension. Am J Respir Crit Care Med 1995; 152:93-97.
3. Phillips BG, Norkiewk K, Perck CA, et al. Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens 1999; 17:61-66.
4. MacLean MR. Endothelin-1 and serotonin: mediators of primary and secondary pulmonary hypertension? J Lab Clin Med 1999; 134:105-144.
5. Tuder RM, Cool CD, Yeager M, et al. The pathobiology of pulmonary hypertension: endothelium. Clin Chest Med 2001; 22:405-418.
6. Taichman D, Mandel J, et al. Epidemiology of pulmonary arterial hypertension. Clin Chest Med 2007; 28:1-22.
7. Simonneau G, Galie N, Rubin LJ, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004; 43 (12 Suppl S):5s-12s.
8. Budev MM, Arroliga AC, Jennings CA. Diagnosis and evaluation of pulmonary hypertension. Cleve Clin J Med 2003; 70:S9-S17.
9. Group IPPHA. The international primary pulmonary hypertension study. Chest supplement 1994; 105:37S-41S.
10. Krowka MJ, Mandell MS, Ramsay MA, et al. Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database. Liver Transpl 2004; 10:174-182.
11. Martin JT, Tautz TJ, Antognini JF. Safety of regional anesthesia in Eisenmen-ger's syndrome. Reg Anesth Pain Med 2002; 27:509-513.
12. RamakrishnaG,SprungJ, Ravi BS, et al. Impact of pulmonary hypertension on the outcomes of noncardiac surgery: predictors of perioperative morbidity and mortality. J Am Coll Cardiol 2005; 45:1691-1699.
13. Roberts NV, Keast PJ. Pulmonary hypertension and pregnancy: a lethal combination. Anaesth Intensive Care 1990; 18:366-374.
14. Tan HP, Markowitz JS, Montgomery RA, et al. Liver transplantation in patients with severe portopulmonary hypertension treated with preoperative chronic intravenous epoprostenol. Liver Transpl 2001; 7:745-749.
15. Weiss BM, Atanassoff PG. Cyanotic congenital heart disease and pregnancy: natural selection, pulmonary hypertension, and anesthesia. J Clin Anesth 1993; 5:332-341.
16. Kahn ML. Eisenmenger's syndrome in pregnancy. N Engl J Med 1993; 329:887.
17. Blaise G, Langleben D, Hubert B. Pulmonary arterial hypertension: pathophysiology and anesthetic approach. Anesthesiology 2003; 99:1415-1432.
18. Nauser TD, Stites SW. Diagnosis and treatment of pulmonary hypertension. Am Fam Phys 2001; 63:1789-1798.
19. Bossone E, Paciacco G, Iarussi D, et al. The prognostic role of the ECG in primary pulmonary hypertension. Chest 2002; 121:513-518.
20. Ahearn GS, Tapson VF, Rebeiz A, Greenfield JC Jr. Electrocardiography to define clinical status in primary pulmonary hypertension and pulmonary hypertension secondary to collagen vascular disease. Chest 2002; 122: 524-527.
21. Pearl RG. Perioperative management of PH: covering all aspects from risk assessment to postoperative considerations. Adv Pulm Hypertens 2005; 4:6-15.
22. Subramaniam K, Yared JP. Management of pulmonary hypertension in the operating room. Semin Cardiothorac Vasc Anesth 2007; 11:119-136.
23. Carmosino MJ, Friesen RH, Doran A, Ivy DD. Perioperative complications in children with pulmonary hypertension undergoing noncardiac surgery or cardiac catheterization. Anesth Analg 2007; 104:521 -527.
24. Weiss BM, Maggiorini M, Jeni R, et al. Pregnant patient with primary pulmonary hypertension: inhaled pulmonary vasodilators and epidural anesthesia for cesarean delivery. Anesthesiology 2000; 92:1191-1194.
25. Kuralay E, Demirkilic U, Oz BS, et al. Primary pulmonary hypertension and coronary artery bypass surgery. J Card Surg 2002; 17:79-80.
26. Cuenco J, Tzeng G, Wittels B. Anesthetic management of the parturient with systemic lupus erythematosus, pulmonary hypertension, and pulmonary edema. Anesthesiology 1999; 91:568-570.
27. Tay SM, Ong BC, Tan SA. Cesarean section in a mother with uncorrected congenital coronary to pulmonary artery fistula. Can J Anaesth 1999; 46:368-371.
28. Rodriguez RM, Pearl RG. Pulmonary hypertension and major surgery. Anesth Analg 1998; 87:812-815.
29. Davies MJ, Beavis RE. Epidural anaesthesia for vascular surgery in a patient with primary pulmonary hypertension. Anaesth Intensive Care 1984; 12:115-117.
30. Weimann J, Ullrich R, Hromi J, et al. Sildenafil is a pulmonary vasodilator in awake lambs with acute pulmonary hypertension. Anesthesiology 2000; 92:1702-1712.
31. Armstrong P. Thoracic epidural anaesthesia and primary pulmonary hypertension. Anaesthesia 1992; 47:496-499.
32. Rich GF, Roos CM, Anderson SM, et al. Direct effects of intravenous anesthetics on pulmonary vascular resistance in the isolated rat lung. Anesth Analg 1994; 78:961-966.
33. Schulte-Sasse U, Hess W, Tarnow J. Pulmonary vascular responses to nitrous oxide in patients with normal and high pulmonary vascular resistance. Anesthesiology 1982; 57:9-13.
34. Tanake H, Tajimi K, Moritsune O, et al. Effects of milrinone on pulmonary vasculature in normal dogs and dogs with pulmonary hypertension. Crit Care Med 1991; 19:68-74.
35. Ichinose F, Roberts JD, Zapol WM. Inhaled nitric oxide: a selective pulmonary vasodilator - current uses and therapeutic potential. Circulation 2004; 109:3106-3111.
36. Kavanaugh BP, Pearl RG. Inhaled nitric oxide in anesthesia and critical care medicine. Int Anesthesiol Clin 1995; 33:181-210.
37. WilkensH,Guth A, Konig J, et al. Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension. Circulation 2001; 104:1218-1222.
38. Atz AM, Lefler AK, Fairbrother DL, et al. Sildenafil augments the effect of inhaled nitric oxide for postoperative pulmonary hypertensive crises. J Thorac Cardiovasc Surg 2002; 124:628-629.
39. Petros AJ, Turner SC, Nunn AJ. Cost implications of using inhaled nitric oxide compared with epoprostenol for pulmonary hypertension. J Pharm Technol 1995; 11:163-166.